The retrospective study focuses on 213 patients at 13 centers with chronic pain who were treated with the system. To date, 140 patients have reached the six months post-implant point.
The study found that there was a reduction in pain from an average baseline score of 7.15, on a 10-point scale, to an average score of 2.93 at the six month mark. In patients with severe back pain, there was a reduction from an average score of 8.78 at baseline to 3.68 at six months post-implant.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
